Speakers:

• Officially opened by Mr Murray Watt, MP - Queensland Parliamentary Secretary to the Minister for Health
• Prof. Peter Andrews - Queensland Chief Scientist; Brisbane, Australia
• Mr David Blake - Blake Industry and Market Analyses Pty Ltd/Bioshares, Australia
• Dr Wing Kai Chan - Director, Department of Medical Research, National Taiwan University Hospital; Taipei, Taiwan
• Dr Daniel Chelsky PhD - Chief Scientific Officer, Caprion Proteomics; Quebec, Canada
• Mr Ben Chen - Managing Director, Burrill & Company; USA
• Dr Jon Chick -  Disease Biology Project Team Leader, Roche Products Ltd; UK
• Prof. Nick Fisk - Director, University of Queensland Centre for Clinical Research; Brisbane, Australia
• Dr Koraljka Gall Troselj - Rudjer Boskovic Institute; Zagreb, Croatia
• Prof. Michael Good - Director, Queensland Institute of Medical Research; Brisbane, Australia
• Prof. Derek Hart - Director, Mater Medical Research Institute; Brisbane, Australia
• Prof. Uwe Heinrich - Executive Director, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM); Chair, Fraunhofer Group for Life Sciences; Hannover, Germany
• Dr. Chris Holloway - Chief Scientific Officer, ERA Consulting (UK) Ltd.; UK
• Prof. Steven Jones - Head, Bioinformatics and Associate Director, Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
• Prof. Dong Ho Lee - Director, Asan Clinical Trial Centre & Vice-President, Korean National Enterprise for Clinical Trials (KoNECT); Seoul, Korea
• Dr David Macfarlane - Deputy Director & Clinical Director (PET), Department of Nuclear Medicine and Queensland PET Services, Royal Brisbane & Women's Hospital; Brisbane, Australia
• Pierre Meulien, PhD - Chief Scientific Officer, Genome British Columbia; Vancouver BC, Canada
• Prof. Robin Mortimer - Queensland Health, Office of Health & Medical Research; Brisbane, Australia
• Dr Masayoshi Murakami - Managing Director and Director for Clinical Research Coordination Department / Vice President, Translational Research Informatics, Center, Foundation for Biomedical Research and Innovation (FBRI); Kobe, Japan
• Prof. Colleen Nelson - Director, Australian Prostate Cancer Research Centre - Queensland; Brisbane, Australia
• Sasha Paegle - Senior Research Product Manager, Microsoft; Redmond, USA
• Dr Tom Pfeifer - Deputy Head, Division of Drug Screening, Centre for Drug Research and Development (CDRD); Vancouver, BC, Canada
• Dr Susan Pond - Adjunct Prof, University of Queensland; Brisbane Australia
• Dr Peter Riddles - Director, Vicibio; Brisbane, Australia
• Prof. Maree Smith - Executive Director, TetraQ; Brisbane, Australia 
• Dr Scott Tebbutt - Scientific Technology Officer of the PROOF Centre for Excellence; British Columbia, Canada
• Mr Fintan Walton - Chief Executive, PharmaVentures Ltd; UK

Click here to view the final program.

Click here to view the speakers' profiles

Thanks to our supporters:

2009 Globally Engaging Events Home Page

Speakers:

• Officially opened by Mr Murray Watt, MP - Queensland Parliamentary Secretary to the Minister for Health
• Prof. Peter Andrews - Queensland Chief Scientist; Brisbane, Australia
• Mr David Blake - Blake Industry and Market Analyses Pty Ltd/Bioshares, Australia
• Dr Wing Kai Chan - Director, Department of Medical Research, National Taiwan University Hospital; Taipei, Taiwan
• Dr Daniel Chelsky PhD - Chief Scientific Officer, Caprion Proteomics; Quebec, Canada
• Mr Ben Chen - Managing Director, Burrill & Company; USA
• Dr Jon Chick -  Disease Biology Project Team Leader, Roche Products Ltd; UK
• Prof. Nick Fisk - Director, University of Queensland Centre for Clinical Research; Brisbane, Australia
• Dr Koraljka Gall Troselj - Rudjer Boskovic Institute; Zagreb, Croatia
• Prof. Michael Good - Director, Queensland Institute of Medical Research; Brisbane, Australia
• Prof. Derek Hart - Director, Mater Medical Research Institute; Brisbane, Australia
• Prof. Uwe Heinrich - Executive Director, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM); Chair, Fraunhofer Group for Life Sciences; Hannover, Germany
• Dr. Chris Holloway - Chief Scientific Officer, ERA Consulting (UK) Ltd.; UK
• Prof. Steven Jones - Head, Bioinformatics and Associate Director, Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
• Prof. Dong Ho Lee - Director, Asan Clinical Trial Centre & Vice-President, Korean National Enterprise for Clinical Trials (KoNECT); Seoul, Korea
• Dr David Macfarlane - Deputy Director & Clinical Director (PET), Department of Nuclear Medicine and Queensland PET Services, Royal Brisbane & Women's Hospital; Brisbane, Australia
• Pierre Meulien, PhD - Chief Scientific Officer, Genome British Columbia; Vancouver BC, Canada
• Prof. Robin Mortimer - Queensland Health, Office of Health & Medical Research; Brisbane, Australia
• Dr Masayoshi Murakami - Managing Director and Director for Clinical Research Coordination Department / Vice President, Translational Research Informatics, Center, Foundation for Biomedical Research and Innovation (FBRI); Kobe, Japan
• Prof. Colleen Nelson - Director, Australian Prostate Cancer Research Centre - Queensland; Brisbane, Australia
• Sasha Paegle - Senior Research Product Manager, Microsoft; Redmond, USA
• Dr Tom Pfeifer - Deputy Head, Division of Drug Screening, Centre for Drug Research and Development (CDRD); Vancouver, BC, Canada
• Dr Susan Pond - Adjunct Prof, University of Queensland; Brisbane Australia
• Dr Peter Riddles - Director, Vicibio; Brisbane, Australia
• Prof. Maree Smith - Executive Director, TetraQ; Brisbane, Australia 
• Dr Scott Tebbutt - Scientific Technology Officer of the PROOF Centre for Excellence; British Columbia, Canada
• Mr Fintan Walton - Chief Executive, PharmaVentures Ltd; UK

Click here to view the final program.

Click here to view the speakers' profiles

Thanks to our supporters:

2009 Globally Engaging Events Home Page